We are live on ! Find out more
OM icon

Outset Medical

99 hedge funds and large institutions have $57.3M invested in Outset Medical in 2026 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 37 increasing their positions, 22 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

68% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 22

14% more capital inflows, than outflows

Capital inflows: $17.2M | Capital outflows: $15M

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 24

1% less funds holding

Funds holding: 100 → 99 (-1)

4.44% less ownership

Funds ownership: 85.7% → 81.27% (-4.4%)

85% less call options, than puts

Call options by funds: $395K | Put options by funds: $2.66M

Holders
99
Holders Change
-1
Holders Change %
-1%
% of All Funds
1.2%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
24
Increased
37
Reduced
22
Closed
24
Calls
$395​K
Puts
$2.66​M
Net Calls
-⁠$2.27​M
Net Calls Change
-⁠$1.71​M

OM Hedge Fund Activity: Q1 2026 in Review

99 of the 8,244 institutional investors tracked by Wall St. Rank reported a position in Outset Medical (OM) for Q1 2026, worth a combined $57.3M — down 1.3% from $58.1M a quarter earlier.

Fund positioning in OM was balanced in Q1 2026: 24 funds opened new positions, 24 closed out, 37 added to existing stakes and 22 trimmed.

The largest buyer was BML Capital Management, adding an estimated $5.57M. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $5.99M sold.

  • 99 institutional investors held Outset Medical (OM) as of Q1 2026, down from 100 in Q4 2025.
  • Funds reported $57.3M of Outset Medical stock for Q1 2026, down 1.3% quarter-over-quarter.
  • 24 funds opened new Outset Medical positions in Q1 2026 and 24 closed out, a net change of 0 holders.
  • The largest Outset Medical buyer in Q1 2026 was BML Capital Management, an estimated $5.57M added.
  • The largest Outset Medical seller in Q1 2026 was Alyeska Investment Group, an estimated $5.99M sold.

Based on aggregated 13F filings for Q1 2026.